InvestorsHub Logo
Followers 1
Posts 16
Boards Moderated 0
Alias Born 07/09/2014

Re: Wolfy3 post# 85125

Thursday, 07/19/2018 9:49:06 PM

Thursday, July 19, 2018 9:49:06 PM

Post# of 144820
Wolfy you've been hitting on a couple things today that I am very sensitive to. You are aboslutely correct. In the real world these "misses" (and i'm using that term broadly) would never be tolerated; there would be real penalties/incentives/ramifications/plans in place to mitigate all of this. I don't really care what the root cause is, be it poor planing by PMCB/AN or other partners...at the end of the day it all sits at the feet of KW. For all those that say that he is working hard, doing the best he can, learning, biologics are hard, etc...well that's all fine except this isn't really a nice guy business where you get to learn on the fly on our dime...he is getting compensated as someone who does not make mistakes, has the i's dotted and t's crossed, knows the details and should have mitigation plans in place accordingly; he is getting compensated as if he knows what he's doing. And that includes the leadership to make sure AN and other partners deliver as properly contractually obligated. Nobody said trying to take an emerging biologic to market is easy, but if someone is going to get compensated as a big boy, then they have to produce...simple as that.

I agree a big company like a Merck would have the proper infrastructure in place to take this up a notch. Problem with that is, what are we worth to a big pharma before proving something? So, although that may be the technically correct approach to move this to fruition, it may not reward the longs here who have and still do believe in the actual technology.

For all the serial haters here, you can kiss my aXX...this is not intended for your little hating world...like it's your job...because it is. Same for the pumpers. Y'all are not that transparent, in spite of what you may think.

Check the managerial incompetence at the door and get this in the clinic to prove or disprove this technology one way or the other.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News